Effectiveness of mobile stroke units in reducing time to thrombolysis in acute ischemic stroke: a scoping review

移动卒中单元在缩短急性缺血性卒中溶栓治疗时间方面的有效性:一项范围界定综述

阅读:1

Abstract

BACKGROUND: Timely thrombolysis within the golden hour (≤ 60 min from onset) is critical for minimizing disability in acute ischemic stroke (AIS). Mobile stroke units (MSUs) enable prehospital thrombolysis, with effectiveness varying by urban versus rural settings, the presence of an onboard neurologist, and telemedicine models. This study maps evidence on MSU effectiveness in reducing time to thrombolysis in AIS compared to standard emergency medical services (EMS), examines factors modulating effectiveness (e.g., geographic setting, operational protocols), and identifies research gaps. METHODS: This scoping review followed the Arksey and O’Malley framework and PRISMA-ScR guidelines. PubMed, Embase, Google Scholar, Scopus, and Cochrane Library were searched from January 2008 to March 2025 for peer-reviewed studies reporting thrombolysis timing in AIS with MSUs. Included randomized controlled trials (RCTs), observational studies, and meta-analyses (using both fixed-effects and random-effects models) were synthesized narratively, with data on time reductions, treatment rates, outcomes, and limitations extracted by two blinded reviewers (NA and EK) and tabulated. RESULTS: Thirteen studies (five RCTs, six observational studies, and two meta-analyses) involving 39,800 patients across urban and mixed settings were included. MSUs reduced the median onset-to-needle time by 20–41 min, increasing golden-hour rates from less than 5% (EMS) to 21–33%. Urban settings reduced time by 25–41 min and onboard neurologists by up to 41 min, compared to 20–40 min in rural areas and 30–37 min with telemedicine. Thrombolysis rates increased by 10–20% with MSUs compared to EMS, with earlier treatment associated with improved 90-day mRS outcomes of 0–1. Gaps include limited rural data, sparse real-world evidence of cost-effectiveness, and inconsistent reporting of outcomes. CONCLUSION: MSUs enhance access to thrombolysis in AIS, resulting in substantial time savings and potential benefits to outcomes, particularly in urban settings. Further research is needed on rural applicability, cost-effectiveness, and standardized outcomes to optimize global MSU implementation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。